Tilray Brands Tilray Brands, a leader in the cannabis industry, recently announced a proposal to execute a . Forward stock ...

Tilray Brands Inc. closed 80.12% short of its 52-week high of $2.31, which the company achieved on May 14th.

Analysts expect Eton Pharmaceuticals to report an earnings per share (EPS) of $0.03. The announcement from Eton ...

A total of 5 analyst ratings have been received for Zevra Therapeutics, with the consensus rating being Buy. The average one-year price target stands at $22.0, suggesting a potential 179.54% upside.

Equities in Canada’s largest lifted themselves Monday, on word the tension between the U.S. and China may be relaxing The TSX Composite Index retained gains of 174.44 points to close Monday at 25,532.

"Volatility is likely to define the cannabis sector in 2025," says Anthony Coniglio, CEO of NewLake Capital Partners, a ...

Canada’s S&P/TSX Composite Index is on track to see its largest reshuffle in nearly three years, driven by strong price divergence across sectors and geopolitical uncertainty, according to Scotiabank ...

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.